Skip to content

Dr. Lotte Hendrix

Active
Private limited company·Activiteiten op het gebied van psychologie· 5 yrs active
Notelaarstraat 294 ·1030 Schaarbeek, Belgium
KBO/BCE: BE 0759.775.561
Watch Print / PDF
Age5 yrs

Summary

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Dr. Lotte Hendrix is 0.3% (very low). The 2025 annual accounts show equity of €1k and a net result of €192k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 7% of 2219 sector peers (fiscal year 2025). The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.

Based on the State Gazette, CBE and 5 annual accounts.

Signals

2 signals · with evidence
Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 7% of 2219 sector peers (2025).
View the sector comparison
Consistently profitable
Positive net result in the two most recent financial years (2024 and 2025).
View the result trend

Signals are derived from the filed annual accounts and the sector comparison. No composite score: each signal is separately verifiable at the source.

Filing behaviour

From the deposit records, complete market-wide
Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-06-2026, 56 days ahead of the deadline. This speaks to administrative punctuality and says nothing about the financial position.
The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
How we compute the deadline
The year end is derived from 5 filed financial years, each closing on 31-12. The statutory deadline is seven months after the close of the financial year (art. 3:10 par. 1 CAC, art. 3:47 par. 7 for ASBL and foundations). Applied to the financial year that closed on 31-12-2025, that is 31-07-2026.
Deadline per financial year
Year closed Due by Filed Variance Reference
31-12-2025 31-07-2026 05-06-2026 56 d early 2026-00142543
31-12-2024 31-07-2025 23-05-2025 69 d early 2025-00105041
31-12-2023 31-07-2024 10-07-2024 21 d early 2024-00233326
31-12-2022 31-07-2023 21-06-2023 40 d early 2023-00147796
31-12-2021 31-07-2022 29-07-2022 2 d early 2022-20243599

Source: the National Bank's deposit records. Those records are complete, including for years whose figures we have not read yet. Filing late covers nearly half the market and is therefore not scored; only not filing, being more than 90 days late and breaking a punctual record carry weight.

Trust signals

2 signals
More than 3 years active
Founded in 2020, past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.

Administrative Flags

No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector Young company +Higher-failure-rate region +

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Financials

TurnoverNot published (abbreviated filing)
EBIT marginNot published (abbreviated filing)
Net result€192k+25.6%
Working capital€-2k

Annual accounts & ratios

Source: NBB · 2025
Annual accounts filed on 05-06-2026 with the NBB · fiscal year 2025 · micro
€0€100k€200k€300kOperating result 2021: €54k€54kNet result 2021: €43k€43kOperating result 2022: €91k€91kNet result 2022: €72k€72kOperating result 2023: €143k€143kNet result 2023: €112k€112kOperating result 2024: €198k€198kNet result 2024: €153k€153kOperating result 2025: €252k€252kNet result 2025: €192k€192k20212022202320242025
Operating resultNet result
Trajectory (indicative)
Projection over 3 fiscal years from the filed annual accounts, not a forecast, the extended trend.
volatile Too volatile to project: the yearly deviation from the trend is ~59% of the level (threshold 35%). We therefore deliberately show no projection line.
€0€100k€200k2021: €44k2022: €116k2023: €225k2024: €154k2025: €1k20212022202320242025
How do we compute this?

The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.

The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.

A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).

Sector comparison
Fiscal year 2025 · NACE 86, Human health · compared within the same schema type (micro schema)
Metric This company Sector median Position in the sector
Solvency 0.9% 58.2%
better than 7% of 2219 sector peers
Net result €192k €60k
better than 90% of 2217 sector peers
Equity €1k €74k
better than 6% of 2219 sector peers
Gross operating margin €255k €95k
better than 87% of 2219 sector peers
Total assets €110k €187k
better than 30% of 2219 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
Sector position over time
Percentile per fiscal year versus peers that filed figures, computed year by year (a year without enough peers is absent).
Solvency P7
2021: P88 · n=18492022: P95 · n=36882023: P92 · n=53522024: P95 · n=65882025: P7 · n=22192021 2025
Stable position over 2021-2025 · n=1849-6588
Net result P90
2021: P51 · n=18492022: P71 · n=36862023: P86 · n=53512024: P89 · n=65822025: P90 · n=22172021 2025
Improving position over 2021-2025 · n=1849-6582
Equity P6
2021: P41 · n=18492022: P72 · n=36882023: P85 · n=53542024: P71 · n=65882025: P6 · n=22192021 2025
Weakening position over 2021-2025 · n=1849-6588
Gross operating margin P87
2021: P42 · n=18502022: P64 · n=36842023: P80 · n=53482024: P85 · n=65902025: P87 · n=22192021 2025
Improving position over 2021-2025 · n=1850-6590
Describes the position versus peers, not a forecast.
EBITDA
€253k
+27.3% 21-25
Net profit
€192k
+25.6% 21-25
Cash flow
€194k
+25.9% 21-25
Total assets
€110k
-30.8% 21-25
Equity
€1k
-99.4% 21-25
Working capital
€-2k
- 21-25
Income taxes
€59k
+29.5% 21-25
Dividends
€345k
+54.3% 21-25
Show 9 other metrics
Debt
€109k
+2355.2% 21-25
Debt ≤ 1y
€109k
+2659.6% 21-25
Current ratio
0.99
-97.5% 21-25
Quick ratio
0.99
-97.5% 21-25
Solvency
0.9%
-99.1% 21-25
Debt / equity
108.68
+378197.9% 21-25
ROE
19234.8%
+19260.5% 21-25
ROA
175.4%
+81.6% 21-25
Interest coverage
673.76
-28.9% 21-25
Figures by fiscal year
Fiscal year2025
Depositmicro
Revenue-
EBITDA€253k
Net profit€192k
Cash flow€194k
Staff costs-
Income taxes€59k
Dividends€345k
Total assets€110k
Equity€1k
Debt€109k
of which ≤ 1y€109k
of which > 1y-
Working capital€-2k
Employees (FTE)-
Ratios (computed)
2025
Current ratio0.99
Quick ratio0.99
Working capital ratio-1.4%
Solvency0.9%
Debt / equity108.68
Long-term debt ratio-
Interest coverage673.76
Gross margin-
Net margin-
ROA175.4%
ROE19234.8%
EBITDA margin-
Days sales outstanding-
Days payable outstanding-
Inventory turnover-
Days inventory (DSI)-
Balance-sheet composition 2025
Full annual accounts (21 line items)
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2025
Balance sheet, Assets
TOTAL ASSETS 20/58€110k
Fixed assets 21/28€3k
Tangible fixed assets 22/27€3k
Current assets 29/58€107k
Amounts receivable within one year 40/41€0
Cash & bank 54/58€7k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€110k
Equity 10/15€1k
Contributions / capital 10/11€1k
Accumulated profits (losses) 14€0
Amounts payable 17/49€109k
Amounts payable within one year 42/48€109k
Trade debts payable within one year 44€2k
Income statement
Gross operating margin 9900€255k
Operating result 9901€252k
Financial income 75€0
Financial charges 65€376
Result before taxes 9903€251k
Income taxes 67/77€59k
Net result for the period 9904€192k
Result to be appropriated 9905€192k
This table shows the latest fiscal year. 4 prior years, with figures and ratios, belong to a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2025 · computed
53 / 100 Fair
050100
Computed from 5 of the 6 factors this model weighs. The rest cannot be derived from the filed figures, or need a prior year to compare against.

The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.

See plans →
Computed by Checked from the NBB filing for FY 2025. Indicative, not credit advice.

Structure & network

Locations & real estate

Registered office

on the map · from the address register
exact location from the address register On OpenStreetMap
3 companies at this address See who is registered here

Establishment units

1 location
Dr. Lotte Hendrix
Notelaarstraat 294, 1030 SchaarbeekOverige dienstverlenende activiteiten op het gebied van informatie, n.e. g.
since 20202.310.968.877
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Parcels1
Ground area573 m²
Buildings1
Building footprint129 m²
Volume (LiDAR)1,522 m³
Tallest building19.9 m · ±5 fl.

Real-estate footprint

Source: CBE × cadastre · address linking

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Brussels 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
21911C0012/00A005 Brussels 573 m² 1 · 129 m² 19.9 m · 5 fl.
Methodology
via registered seat: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Publications

Lifecycle & Insolvency Signals

No insolvency signals in the Belgian State Gazette

Belgisch Staatsblad · acts

1 acts
Address history · 1
13-08-2024
Registered-office move
All acts · 1 updated 2 years ago
2024
13-08-2024 Registered office moved from Leuven to Schaarbeek Registered-office change·Dr. Lotte Hendrix
  • 3001 Leuven, Brugstraat 105 → 1030 Schaarbeek, Rue du Nover 294
Notary: Dr. Lotte Hendrix · Leuven

Analysis

Financial profile

5 of 5 axes measured
Health53Profitability100Solvency11Growth58Stability94
63 / 100

Strong profile, led by profitability.

All 5 axes are computed from data Checked has read.

Health 53
Profitability 100
Solvency 11
Growth 58
Stability 94

Credit advice

verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.

Similar

Similar companies

Comparable size, same sector

Company registry

Company registry (CBE)

Crossroads Bank
Activities
Activiteiten op het vlak van geestelijke gezondheidszorg, m.u.v. psychiatrische ziekenhuizen en verzorgingstehuizen86904Activiteiten op het gebied van psychologie86931Overige hospitalisatiediensten86109Activiteiten van huisartspraktijken86210Activiteiten van medisch specialisten86220Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten op het gebied van voeding86995
Primary activity highlighted.
Names & trade names
Legal nameNL Dr. Lotte Hendrix
Registered office
Notelaarstraat 294
1030 Schaarbeek, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.